US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 24, 2023 (3 years ago)

Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.

What was recalled

Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC 0338-0067-01

Recalling firm
Baxter Healthcare Corporation
NDC code
0338-0067-01
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0048-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all